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Introduction: Academic detailing is an interactive educational outreach to prescribers to
present unbiased, non-commercial, evidence-based information, mostly about medications,
with the goal of improving patient care. Academic detailing in Norway is an approach for
providing continuing medical education to general practitioners (GPs). The basis of academic
detailing is a one-to-one discussion between a trained health professional (the academic
detailer) and the GP at the GP’s workplace.
Method: Our first campaign was named “Better use of non-steroidal anti-inflammatory
drugs (NSAIDs)”, which aim was to reduce the use of diclofenac due to the risk of serious
cardiovascular adverse events. At the same time we advised the GPs to use naproxen as the
drug of choice if an NSAID was needed. We did a one-to-one intervention in two cities,
where a trained academic detailer met the GP during office hours. A total of 247 GPs were
invited to participate and 213 visits (86%) were completed. This article reviews the theore-
tical framework underlying the method and describes the development and implementation
of academic detailing to GPs in Norway.
Results: More than 90% the participating GPs considered academic detailing a suitable
method for providing up-to-date evidence-based, manufacturer-independent information, and
nearly all would most likely or probably welcome another visit. After the intervention there
was a reduction of diclofenac prescribing of 16% and 18%, respectively, in the two cities.
Conclusion: We consider that academic detailing is a suitable method to bring the best
available evidence to the point at which care is delivered, to achieve the best for the patients.
According to the Norwegian GPs’ evaluation, it is a key supplement to other methods of
continuing medical education. To have maximum impact, it is important that academic
detailing is practiced according to the consensus that has evolved in the USA and Australia.
Keywords: academic detailing, educational outreach visits, general practitioners, general
practice, quality improvement
Introduction
It is virtually impossible for general practitioners (GPs) to be fully updated on all
guidelines for all existing therapies. Several methods are used to obtain new and
updated information, including congress participations, courses and seminars, group
meetings with peers and self-studies. In 1983, Jerry Avorn and Stephen Soumerai
published two articles in which they introduced a new method for providing
evidence-based manufacturer-independent information for GPs, termed Academic
detailing (AD).1,2 Since then the method has been used in several countries,
especially Australia, USA and Canada3–7 as a strategy to enhance prescription
decisions in general practice. However, the use of AD in Europe is minimal.
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The basis of AD as defined in this article is a face-to-
face discussion by a trained health professional, usually
termed academic detailer (or clinical facilitator), in a one-
to-one setting in the prescriber’s workplace during office
hours. As a behaviour change intervention, one-to-one
visits have shown to be more effective than group meet-
ings with peer discussions.6–12 The term AD has also been
used to describe other approaches as group meetings and
small seminars.13–15 Both one-to-one visits and group
meetings have advantages and disadvantages, as shown
in Table 1.
We searched PubMed and Embase after publications
describing AD in Europe. We identified a total of 62
articles, but only 7 (11%) of those described a method
were the prescriber was visited in a one-to-one setting.
Thus, the use of the term AD is not unambiguous. We
agree with bodies such as The Society for Academic
Continuing Medical Education14 that the term AD
should be reserved for one-to-one meetings as described
and that studies should more clearly define the method
used.
The steps of AD described in 1983 still form the basis
of AD today1,2,13 (Box 1). The aim of this article is to
review the theoretical framework underlying the method
and to describe the development and implementation of
academic detailing to GPs in Norway.
Method
Theoretical framework
For successful AD it is of crucial importance that the aca-
demic detailers are trained both in the method of AD and the
best available evidence in the specific therapeutic area to be
presented. This training allows the academic detailers to
build necessary background and communication skills to
engage in a collaborative dialog with the GP, to assess the
GP’s needs and at the same time be aware of the GP’s
attitudes, beliefs and values. The academic detailer is speci-
fically trained to use open questions in the dialog. For exam-
ple; “What is your experience in dealing with patients in this
area?”, “Which adverse events do you see as the most com-
mon when using this medication?”, “How do you deal with
this adverse event?”. Thus, information can be tailored on an
individual basis. In the training, the academic detailer also
practices communication skills, such as minimal enablers, to
encourage a two-way conversation and reflecting skills, mak-
ing sure that the academic detailer understands the views
being expressed by the GP in the ongoing dialog.
Table 1 Advantages and disadvantages with academic detailing versus group meetings as methods for changing drug prescribing




● Time-effective for the GPb
● Messages can be tailored to the GP’s current understanding
and behaviour
● One-to-one interaction keeps focus
● More effective than other methods for changing prescribing
● Time-consuming for the academic detailer
● Higher costs than group visits




● Time-effective for the academic detailer (approximately
45 mins for a group meeting to see all GPs in a practice)
● Lower costs than one-to-one visits
● In a good group setting sharing and discussion with collea-
gues is possible
● More time-consuming for the GP than a 20 mins one-to-one
meeting
● Difficult to tailor the messages to the individual GPs
● Easier for the GP to be unfocused than during a one-to-one visit
● The group setting can be a barrier for the individual GP to ask
questions
Notes: aThe term “academic detailing” is here specifically used to describe a one-to-one visit. bIn Norway, the scheduled time for a one-to-one visit is 20 mins.
Box 1 The steps of academic detailing1,2,13
● Focusing programs on specific categories of physicians as well as on
their opinion leader.
● Investigating baseline knowledge and motivations for current activity.
● Defining clear educational and behavioral objectives.
● Establishing credibility through a respected organizational identity,
referencing authoritative and unbiased sources of information, and
presenting both sides of controversial issues.
● Stimulating active participation by physicians in educational interactions.
● Using concise graphic educational materials that highlight and repeat
essential messages.
● Providing positive reinforcement of improved practices at follow-up
visits.
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Influencing professional behaviour change is complex
and is increasingly being studied to better understand
how to optimize the effectiveness of an intervention in
different contexts and reduce the evidence-to-practice
gap among GPs in a cost-effective manner. AD is influ-
enced by social marketing theory,13 transtheoretical mod-
els of behaviour change and social cognitive theory.
Figure 1, from the book Drug Utilization Research:
Methods and Applications, highlights the complexity of
practice change. For example, while it is recognized that
guidelines alone may not affect professional behaviour
change, they can be a component or part of the process
from contemplation, awareness rising and knowledge
building to reflection and rehearsal. These processes
overlap in real life and are necessary for skill develop-
ment and creation of motivation for change. The model
helps to provide a theoretical basis and understanding of
the relationship between multiple events across time that
influence behavioural changes including medication use.
In Figure 1, AD is placed under “Skill development” but
it also has a place under “Motivation” and under
“Reinforcement” when the GP is revisited.
When designing an AD campaign, updated evidence
from internationally acknowledged sources should be
gathered and reviewed by a group of professionals in the
field, a priori key messages should be determined and
educational material should be developed.
Academic detailing in Norway
The Department of Clinical Pharmacology and the
Regional Medicines Information and Pharmacovigilance
Center (RELIS) in Trondheim have been offering group
education and participated in educational outreach visits to
GPs over many years,17,18 typically during lunch hours or
as half-day or full-day courses. Although group meetings
are an efficient method to reach many GPs within a short
period of time, this kind of education has limited impact.19
In addition, there are many potential disruptions, for exam-
ple participants coming in or leaving the lunchroom during
the session, checking e-mails and answering phone calls.
Some key differences between AD and group meetings are
presented in Table 1.
We wanted to implement AD in primary care in
Norway, and received funding from the Norwegian
Ministry of Health to perform a study in two cities,
Tromsoe and Trondheim. Medical doctors (specialists in
clinical pharmacology and junior doctors) and pharmacists
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Maintenance
Figure 1 The complexity of practice change and the underlying theoretical frameworks. Academic detailing is placed under “Skill development” but it also has a place under
“Motivation” and under “Reinforcement” when the general practitioner is revisited. Data f rom Elseviers M et al drug utilization research: methods and applications, Wiley-
Blackwell, 2016, page 474. With permission from Wiley-Blackwell.16
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RELIS were trained to be academic detailers. The training
was undertaken over three days by an experienced AD
teacher from The Drug and Therapeutic Information
Service (DATIS) in Adelaide, Australia, following the
same model as the courses in Australia. Education and
training are crucial to ensure that the academic detailers
have the competence to conduct an updating visit to max-
imize the impact of AD.14,15,20 To carry out a successful
updating visit open questions is essential to facilitate the
dialog11,21 - the academic detailer must continuously
assess the clinician’s individual needs throughout the dis-
cussion. The academic detailers were trained to present a
topic consistently while meeting the needs of individual
GPs together with how to respond to questions. At the
conclusion of the seminar the participants were filmed
performing an AD visit to a local GP who was engaged
to participate in the training. The film was used by the
academic detailers for self-reflection, eg to consider body
language and general attitude.
The first campaign was named “Better use of non-ster-
oidal anti-inflammatory drugs (NSAIDs)”. In 2013, the
European Medicines Agency (EMA)22 and the Norwegian
Medicines Agency23 published new safety advice for diclo-
fenac based on an increased risk for cardiovascular disease.
Nevertheless, diclofenac continued to be the most fre-
quently prescribed NSAID in Norway. We therefore con-
cluded that prescription of NSAIDs would be a suitable
topic for AD.
First, we carried out a literature search in the
PubMed and Embase databases to identify the most
recently updated knowledge in the area. A group of
clinical pharmacologists, pharmacists, GPs, a nephrolo-
gist and a geriatrician worked together to distil the most
important knowledge for the AD brochure. The distilled
evidence-based material was presented in a four-page
brochure. The most important content was broken
down to 4–5 key messages, which were outlined on
the front page of the brochure, while the rest of the
brochure was used to provide the evidence behind the
key messages, background information and reference
citations. By such a procedure, a guideline of 50–200
pages can be condensed to present the most important
aspects of a therapeutic guideline in a visually engaging
format during the course of a relatively short updating
visit.
The impact of the campaign was evaluated using data
from the Norwegian Prescription Database (NorPD)24 cov-
ering a period of 12 months before and after the
intervention. Prescription data was analysed with inter-
rupted time series analysis. Full results of these analyses
are published elsewhere.25
In most of the available literature there is no specifi-
cation of the time frame for an AD visit. In Norway we
chose to use 20 mins for the visit, as this is the time
interval used for an ordinary patient consultation in gen-
eral practice. Actual mean time for the visits in our
campaign was 24 mins. When the visits took longer
than the planned 20 mins, it was initiated by the GP,
usually by asking further questions. In a few cases, the
visit lasted considerably longer, up to 60 mins. In con-
trast, the shortest visit was only 10 mins. It all depended
on the interest of the GP and the willingness to engage in
the dialog. All GPs did engage to some degree, but most
of them also wanted us to be able to finish the documen-
tation of our key messages within the scheduled time
frame of 20 mins.
After the one-to-one visit the academic detailer
documented information about who was visited, dura-
tion of the visit, whether the whole brochure was pre-
sented or not, whether the GP seemed interested in the
topic, and whether the GP suggested future topics of
interest. If the academic detailer had been unable to
answer specific questions during the visit, he or she
brought the question back to the center to review the
literature and/or discuss it with the team. Thereafter the
answer was forwarded to the GP either by phone or by
e-mail. Irrespective of any questions, the GP’s e-mail
address was registered in order to send an evaluation
form after the visit.
When revisiting a GP with a new campaign, key mes-
sages from the previous visit would be repeated as a
reinforcement.
AD in Norway is solely an updating service. We do
not examine the GP’s actual practice data, but give the
GP an opportunity to reflect on whether his/her own
practice is in accordance with the best available evidence,
and make a change if needed. All GPs in the two cities
were offered a visit, regardless of their prescribing pat-
tern. The life cycle of a Norwegian AD program is pre-
sented in Figure 2.
Results
Our campaign was named “Better use of non-steroidal
anti-inflammatory drugs (NSAIDs)”, which advised GPs
to reduce the use of diclofenac due to increased risk of
serious cardiovascular adverse events, and at the same
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time we advised the GPs to use naproxen as drug of choice
if an NSAID was needed, as naproxen has a more advan-
tageous cardiovascular adverse event profile.26 In addition,
we advised the GPs to generally avoid NSAIDs in the
elderly.
The campaign took place between March and May
2015. A total of 247 GPs were invited to participate and
213 visits (86%) were completed. All participating GPs
received an electronic questionnaire by e-mail to evaluate
the visit. Of the 213 GPs visited, 169 (79%) completed the
questionnaire. As this evaluation did not involve any
patients, approval from an Ethical Committee was not
needed according to Norwegian legislation. The principal
results from the evaluation are shown in Table 2.
Post-intervention prescribing effects were quite
immediate and showed statistically significant results
with a reduction of diclofenac prescribing of 16% and
18%, respectively, in the two cities where the campaign
was carried out, relative to the rest of the country.25 The
results are depicted in detail in Figures 3 and 4 where the
changes in the prescription of diclofenac and naproxen in
the two study cities are compared with the rest of the
















































Figure 2 The life cycle of the academic detailing program in Norway.
Table 2 Norwegian general practitioners’ evaluation of the academic detailing campaign (n=213)
Question Percent “yes”, NSAIDs campaign
Were 20 mins a suitable time frame for the topic? 92%
Did you get useful information about the topic? 98%
Was the topic relevant for your practice? 99%
Is academic detailing a suitable method for producer-independent, evidence-based information? 90%
Would you probably or most probably welcome a new visit on another topic? 98%
Abbreviation: NSAIDs, non-steroidal anti-inflammatory drugs.
Dovepress Dyrkorn et al
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Discussion
The key findings in this study was that post-intervention
prescribing showed a reduction of diclofenac prescribing
of 16–18% and that 90% of the participating GPs consid-
ered academic detailing a suitable method for keeping
them up-to-date and 98% would probably or most prob-
ably welcome another visit. These numbers are about the
same as those found in a study from France.27 The GPs
were also very satisfied with the chosen visit duration of
20 mins. This is in accordance with our own experience
A
B
Figure 3 Actual and modelled prescription of diclofenac 12 months before and after the academic detailing campaign (vertical dashed line) targeting general practitioners in
the cities of Trondheim (A) and Tromsoe (B), compared with the rest of Norway. Reproduced under the terms of the creative commons attribution 4.0 international licence
(http://creativecommons.org/licenses/by/4.0/); Langaas HC, Hurley E, Dyrkorn R, Spigset O. Effectiveness of an academic detailing intervention in primary care on the
prescribing of non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 2019;75(4):577–86.25
Dyrkorn et al Dovepress
submit your manuscript | www.dovepress.com
DovePress









































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
indicating that 20 mins generally is sufficient to discuss
the key messages, present the background documentation
and, most importantly, to ensure that the academic detailer
engages in a dialog with the GP. Some visits take longer
and some shorter time, as individual needs and the eager-
ness to discuss and oppose differs between GPs. The time
used is shorter than in other countries. In Australia the
average appointment time booked is 30 mins and the
average time used is 38 mins (unpublished data, Drug
and Therapeutics Information Service). Van Hoof et al
found that the time frame was about 60 mins in their
review article on Characteristics of Academic Detailing.14
A
B
Figure 4 Actual and modelled prescription of naproxen 12 months before and after the academic detailing campaign (vertical dashed line) targeting general practitioners in
the cities of Trondheim (A) and Tromsoe (B), compared with the rest of Norway. (Reproduced under the terms of the creative commons attribution 4.0 international
licence (http://creativecommons.org/licenses/by/4.0/)). Langaas HC, Hurley E, Dyrkorn R, Spigset O. Effectiveness of an academic detailing intervention in primary care on
the prescribing of non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 2019;75(4):577–86.25
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As we now have started new campaigns in other thera-
peutic areas, we have experienced that when visiting a GP for
a second time, repeating and discussing key messages from
the previous visit, some of the GPs are willing to share
whether they have changed their practice. They had most
often not proceeded through all the stages of changes, but
instead moved straight to action. We believe that the main
reason for this swift response is the trust and credibility
towards the academic detailer and the synthesized practical
material. This process is referred to as “cognitive
debiasing”28 and is a heuristic or short-cut approach for
clinical decision making, and can possibly explain the
immediate prescribing changes after the intervention. This
outcome presupposes a high awareness for the AD service
providers to ensure that the program content is reliable and
up-to-date, and that the academic detailer is well trained in
presenting the clinical content correctly. Another factor could
be the simple message presented in the NSAID campaign;
prescribing another drug within the same class and with the
same therapeutic effect which is not particularly complicated
to perform for the GP in the clinical setting.
Independence from commercial interests as well as from
the health authorities was emphasized by many of the GPs
as a factor that increased credibility. Even though our cam-
paign was funded by a public grant our organization devel-
oped the materials independently and was perceived as
independent by most of the GPs. Others have also shown
that users of AD highly appreciate its educational value and,
due to their positive experience with AD, tend to view
information from other sources and other forms of continu-
ing medical education more critically.29 In a study from
Belgium, the GPs concluded that the visits were a credible
and interesting way of receiving continuing medical educa-
tion and that they both enhanced their knowledge and
increased their reflections on their own prescribing
behaviour.30 That the service is free for the GP and that
the GP does not have to leave the office eliminates the need
for travel and minimizes any loss of income for the GP.
Conclusion
AD as a method is gradually expanding to new countries and
is well suited for professional updating among GPs. Several
studies have shown that AD is the most effective method
to ignite motivation for behavioural change among
GPs.6–8,12,19,29 The method is based on encouragement and
reflection to achieve voluntary action, rather than coercion or
enforcement. It brings the best available evidence to the point
at which care is delivered and can be tailored to meet the
individual needs of the doctors, to achieve the best for their
patients. According to the Norwegian GPs’ evaluation it is a
key supplement to other methods of professional updating. In
order to evaluate the method even more thoroughly, we agree
with bodies such as The Society for Academic Continuing
Medical Education,14 and strongly recommend that future
studies should more clearly define and explain the specific
method used, and that the term AD should be reserved for
one-to-one meetings.
Key message
● Several studies have shown that academic detailing is
the most effective method to ignite motivation for
behavioural change among general practitioners.
● We have developed and implemented the method in
Norway.
● According to the general practitioners’ evaluation aca-
demic detailing is a welcome activity and a key supple-
ment to other methods of professional updating.
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